Using Multiple Targeted Therapies in Oncology: Considerations for Use, and Progress to Date in Breast Cancer

There has been significant progress in our basic understanding of drugs and targets in the management of breast cancer. Recent breast cancer clinical trials have examined whether combinations of drugs targeting transmembrane receptors or their downstream effectors involved in cell signal transduction can increase response rates and overcome acquired and/or… CONTINUE READING